Prince Akwasi Mensah

Array ( [id] => 3497171 [patent_doc_number] => 05532265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/348262 [patent_app_country] => US [patent_app_date] => 1994-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5291 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532265.pdf [firstpage_image] =>[orig_patent_app_number] => 348262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787588 [patent_doc_number] => 05736542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Pharmaceutical compositions containing a staurosporine' [patent_app_type] => 1 [patent_app_number] => 8/343404 [patent_app_country] => US [patent_app_date] => 1994-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736542.pdf [firstpage_image] =>[orig_patent_app_number] => 343404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510630 [patent_doc_number] => 05512275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Topical lotion and method for treatment of androgenic alopecia' [patent_app_type] => 1 [patent_app_number] => 8/343647 [patent_app_country] => US [patent_app_date] => 1994-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3317 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512275.pdf [firstpage_image] =>[orig_patent_app_number] => 343647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3851108 [patent_doc_number] => 05767117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Method for treating vascular headaches' [patent_app_type] => 1 [patent_app_number] => 8/342090 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6323 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767117.pdf [firstpage_image] =>[orig_patent_app_number] => 342090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3581726 [patent_doc_number] => 05498630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Fungicides for the control of take-all disease of plants' [patent_app_type] => 1 [patent_app_number] => 8/340573 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41175 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 401 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498630.pdf [firstpage_image] =>[orig_patent_app_number] => 340573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648132 [patent_doc_number] => 05629300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Drug containing (-)-metriphonate' [patent_app_type] => 1 [patent_app_number] => 8/331643 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 917 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629300.pdf [firstpage_image] =>[orig_patent_app_number] => 331643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843163 [patent_doc_number] => 05708014 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Method for treating anxiety' [patent_app_type] => 1 [patent_app_number] => 8/336454 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9974 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2614 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708014.pdf [firstpage_image] =>[orig_patent_app_number] => 336454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587116 [patent_doc_number] => 05552403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/332029 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5601 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552403.pdf [firstpage_image] =>[orig_patent_app_number] => 332029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3533504 [patent_doc_number] => 05556847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/330534 [patent_app_country] => US [patent_app_date] => 1994-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4936 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556847.pdf [firstpage_image] =>[orig_patent_app_number] => 330534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562049 [patent_doc_number] => 05525596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound' [patent_app_type] => 1 [patent_app_number] => 8/327081 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3282 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525596.pdf [firstpage_image] =>[orig_patent_app_number] => 327081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657467 [patent_doc_number] => 05658881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Method for topical inhibition of the metabolic activity of cytochrome P450' [patent_app_type] => 1 [patent_app_number] => 8/323267 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2178 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658881.pdf [firstpage_image] =>[orig_patent_app_number] => 323267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3553063 [patent_doc_number] => 05492915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-20 [patent_title] => 'Substituted quinolyl compounds exhibiting selective leukotriene B.sub.4 antagonist activity' [patent_app_type] => 1 [patent_app_number] => 8/318919 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26709 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/492/05492915.pdf [firstpage_image] =>[orig_patent_app_number] => 318919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3840174 [patent_doc_number] => 05744482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine' [patent_app_type] => 1 [patent_app_number] => 8/318391 [patent_app_country] => US [patent_app_date] => 1994-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11398 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744482.pdf [firstpage_image] =>[orig_patent_app_number] => 318391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3736293 [patent_doc_number] => 05698571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => '5-HT.sub.1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine' [patent_app_type] => 1 [patent_app_number] => 8/318330 [patent_app_country] => US [patent_app_date] => 1994-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8808 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698571.pdf [firstpage_image] =>[orig_patent_app_number] => 318330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662435 [patent_doc_number] => 05656669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Restorative neuropharmacological agent for motor and speech disturbance' [patent_app_type] => 1 [patent_app_number] => 8/317392 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656669.pdf [firstpage_image] =>[orig_patent_app_number] => 317392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3107635 [patent_doc_number] => 05418251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-23 [patent_title] => 'Topical composition for accelerating wound healing' [patent_app_type] => 1 [patent_app_number] => 8/313609 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2763 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/418/05418251.pdf [firstpage_image] =>[orig_patent_app_number] => 313609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612934 [patent_doc_number] => 05565468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Pyridino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents' [patent_app_type] => 1 [patent_app_number] => 8/313684 [patent_app_country] => US [patent_app_date] => 1994-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17607 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 322 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565468.pdf [firstpage_image] =>[orig_patent_app_number] => 313684 [rel_patent_id] =>[rel_patent_doc_number] =>)